Buchumschlag

Routine characterization of biomarkers in non-small cell lung carcinoma: how much is enough?

Fuente: Redalyc

Gespeichert in:

Bibliographische Detailangaben
1. Verfasser:	José Carlos Machado
Format:	Artículo científico
Sprache:	en
Veröffentlicht:	Sociedade Portuguesa de Pneumologia 2015
Schlagworte:	Medicina
Online-Zugang:	Acceder al recurso
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge

Adjuvant chemotherapy in stage IB non-small cell lung carcinoma: A survival analysis
von: D. Coutinho
Veröffentlicht: (2016)

Immune checkpoint expression as prognostic biomarker candidates in non‐small cell lung carcinoma patients
von: Débora Maria Porto, et al.
Veröffentlicht: (2024)

Endobronchial ultrasound-guided transbronchial needle aspiration for nodal staging in non-small cell lung carcinoma
von: D. Coutinho
Veröffentlicht: (2017)

Supplementary Information: From weather to system extremes - how much data is enough?
von: Fürmann, Tim
Veröffentlicht: (2025)

Cell-free DNA in non-small cell lung cancer
von: Vaida Gedvilaitė
Veröffentlicht: (2017)

Macroeconomic stability in developing countries : how much in enough? / Peter Montiel, Luis Servén
von: Montiel, Peter
Veröffentlicht: (2004)

Establishment, culture and characterization of gemcitabine hydrochloride‐resistant human non‐small cell lung carcinoma cell line derived cancer stem cells
von: Bahar Demir Cevizlidere, et al.
Veröffentlicht: (2024)

Face 2-phase: how much overdetermination is enough to get symmetry in two-phase problems
von: Cavallina, Lorenzo, et al.
Veröffentlicht: (2023)

Impact of concurrent medications on the outcome of immunotherapy in non‐small cell lung carcinoma
von: Jun Yamada, et al.
Veröffentlicht: (2024)

How much prophylaxis is enough in haemophilia?
von: Manuel Carcao, et al.
Veröffentlicht: (2024)

Survival analysis of patients with non-small cell lung cancer treated by surgery with curative intent
von: C. Cruz
Veröffentlicht: (2017)

Clinicopathological and molecular characterization of non–small cell lung cancer with pericardial effusions
von: Weijie Ma, et al.
Veröffentlicht: (2025)

PARP inhibitors induce a senescence phenotype in non‐small cell lung carcinoma cell lines
von: Camille Huart, et al.
Veröffentlicht: (2026)

Early pembrolizumab clearance as prognostic biomarker for non‐response in patients with advanced non‐small cell lung cancer
von: Fenna de Vries, et al.
Veröffentlicht: (2025)

Is diabetes mellitus a negative prognostic factor for the treatment of advanced non-small-cell lung cancer?
von: Ali Inal
Veröffentlicht: (2014)

Hepatocellular carcinoma (HCC) biomarkers in Colombia
von: MARÍA-CRISTINA NAVAS
Veröffentlicht: (2007)

Cost-effectiveness of pemetrexed in combination with cisplatin as first line treatment for patients with advanced non-squamous non-small-cell lung cancer in Spain
von: Jonathan González García
Veröffentlicht: (2017)

RBBP4: A novel diagnostic and prognostic biomarker for non‐small‐cell lung cancer correlated with autophagic cell death
von: Yajing Zhan, et al.
Veröffentlicht: (2024)

Plasma extrachromosomal circular DNA as a biomarker in EGFR ‐targeted therapy of non‐small cell lung cancer
von: Simone Stensgaard, et al.
Veröffentlicht: (2025)

Circulating levels of galectin‐9 are a potential biomarker of survival in advanced non‐small‐cell lung cancer
von: Guilherme Vieira de Mendonça Filho, et al.
Veröffentlicht: (2024)

Prediction performance comparison of biomarkers for response to immune checkpoint inhibitors in advanced non‐small cell lung cancer
von: Jie Zhao, et al.
Veröffentlicht: (2024)

Spindle-cell carcinoma of the prostate
von: Carlos Hirokatsu Watanabe Silva
Veröffentlicht: (2012)

Sudden onset acute liver failure in a patient with clinically occult small cell lung carcinoma: autopsy report and review of the medical literature
von: Massimiliano Guerriero
Veröffentlicht: (2019)

Circulating genomic biomarkers predict chemoradiotherapy resistance and immunotherapy response in locally advanced non‐small‐cell lung cancer
von: Yu Wang, et al.
Veröffentlicht: (2025)

Identification of protein biomarkers for prediction of response to platinum‐based treatment regimens in patients with non‐small cell lung cancer
von: Franziska Böttger, et al.
Veröffentlicht: (2024)

Correction to “ KBTBD7 promotes non‐small cell lung carcinoma progression by enhancing ubiquitin‐dependent degradation of PTEN ”
Veröffentlicht: (2024)

CEO incentives—It's not how much you pay, but how
von: Michael C. Jensen, et al.
Veröffentlicht: (2024)

Mandible metastasis of small cell lung cancer mimicking a residual cyst
von: Renata Mendonça Moraes
Veröffentlicht: (2017)

Labour market flexibility in the transition countries: how much is too much?
von: Sandrine Cazes, et al.
Veröffentlicht: (2001)

Occipital condyle syndrome due to small‐cell lung carcinoma: A case report
von: Satoshi Yamashita, et al.
Veröffentlicht: (2024)

Nintedanib in combination with docetaxel for second-line treatment of advanced non-small-cell lung cancer; GENESIS-SEFH drug evaluation reporta
von: María Espinosa Bosch
Veröffentlicht: (2016)

The association of nutritional and inflammatory biomarkers with overall survival in patients with non‐small‐cell lung cancer treated with immune checkpoint inhibitors
von: I. M. Horstman, et al.
Veröffentlicht: (2024)

Tumour hepcidin levels as a biomarker for predicting response to immune checkpoint inhibition in advanced non‐small cell lung cancer
von: Yuichiro Suzukawa, et al.
Veröffentlicht: (2026)

A combined small cell lung carcinoma patient with only small cell carcinoma components in mediastinal lymph node metastasis and chondrosarcoma‐like components in liver metastasis
von: Takako Kawaguchi, et al.
Veröffentlicht: (2024)

Unusual presentation of high-grade neuroendocrine carcinoma of the Urinary bladder with small-cell and large-cell features
von: Vitor Fiorin de Vasconcellos
Veröffentlicht: (2013)

Establishing how much improvement in lung function and distance walked is clinically important for adult patients with Pompe disease
von: Aglina Lika, et al.
Veröffentlicht: (2024)

Bilateral Virchow nodes: an unusual finding of pulmonary small-cell neuroendocrine carcinoma metastasis
von: Matthew J. Zdilla
Veröffentlicht: (2023)

Current medical device regulation: Is that enough?
von: Juan Francisco Márquez-Peiró
Veröffentlicht: (2019)

Resurgence of morphology: Discarded small cell lung carcinoma subtypes reflect current molecular classification
von: Hironori Ninomiya
Veröffentlicht: (2024)

ILT4 facilitates angiogenesis in non‐small cell lung cancer
von: Shuyun Wang, et al.
Veröffentlicht: (2024)